Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Market Movers Today: Rovio Entertainment Oyj (ROVVF), Nektar Therapeutics (NKTR), J C Penney Company Inc (JCP), Gap Inc (GPS), and More

Rovio Entertainment Oyj (OTCMKTS:ROVVF) (MarketWatch)
Shares in Rovio Entertainment Ltd. (ROVIO.HE) sank further Friday after it warned that competition has intensified while the performance of its new games titles has fallen short of expectations. The Finnish developer behind the “Angry Birds” mobile-gaming franchise last week warned that its revenue growth is losing steam as it struggles to attract and retain new players. Following that announcement the stock lost half of its value. In a separate announcement Friday, Rovio said the head of its games business, Wilhelm Taht, will leave the company immediately “due to personal reasons.” Chief Executive Kati Levoranta will act as head of games for the time being, the company said.

Nektar Therapeutics (NASDAQ:NKTR) (The Motley Fool)
What happened: In response to reporting expectation-thumping results, shares of Nektar Therapeutics (NASDAQ:NKTR), a biotech focused on cancer, auto-immune disease, and chronic pain, jumped 18% as of 11:20 a.m. EST on Friday. So what: Here’s a look at the headline numbers from the quarter: Revenue of $95.5 million crushed Wall Street’s expectation of $31.5 million. Even if you subtract the $60 million in revenue related to a new sublicense agreement, the total would have still come in ahead of the consensus estimate. Net loss was $0.21 per share. That was far lower than the $0.38 loss that analysts had expected.

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart


J C Penney Company Inc (NYSE:JCP) (Reuters)
(Reuters) – J.C. Penney Co Inc (JCP.N) forecast broadly lower-than-expected full-year profit on Friday as the department store operator grapples with weak demand for its clothes and fierce online competition, sending its stock down 10 percent. The downbeat forecast, on top of fourth-quarter same-store sales below Wall Street’s estimates, surprised investors after the retailer said in January it had seen strong demand for home, beauty products and jewelry during the holiday shopping season.

Gap – Gap reported adjusted quarterly profit of 61 cents per share, 3 cents a share above estimates. The clothing retailer’s revenue also topped forecasts. The parent of the Gap, Old Navy, and Banana Republic chains also saw comparable-store sales rise by 5 percent. Gap also issued stronger-than-expected 2018 guidance and raised its quarterly dividend by 5 percent.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.